2B55

ICD-11 MMS 2026-01

Rhabdomyosarcoma, primary site

Description

Rhabdomyosarcoma is a malignant soft tissue tumour which develops from cells of striated muscle. It is the most common form of tumour found in children and adolescents.

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Exclusions from above levels

  • 2A01.1 – Mesenchymal tumour of meninges
  • 2A02.1 – Tumours of cranial or paraspinal nerves
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
Show allHide
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Child codes

  • 2B55.0 – Rhabdomyosarcoma of the oral cavity or pharynx
  • 2B55.1 – Rhabdomyosarcoma of respiratory or intrathoracic organs
  • 2B55.2 – Rhabdomyosarcoma of male genital organs
  • 2B55.Y – Rhabdomyosarcoma, other specified primary site
  • 2B55.Z – Rhabdomyosarcoma, unspecified primary site

Sibling codes

  • 2B50 – Chondrosarcoma, primary site
  • 2B51 – Osteosarcoma, primary site
  • 2B52 – Ewing sarcoma, primary site
  • 2B53 – Fibroblastic or myofibroblastic tumour, primary site
  • 2B54 – Undifferentiated pleomorphic sarcoma, primary site
  • 2B56 – Angiosarcoma, primary site
  • 2B57 – Kaposi sarcoma, primary site
  • 2B58 – Leiomyosarcoma, primary site
  • 2B59 – Liposarcoma, primary site
  • 2B5A – Synovial sarcoma, primary site
  • 2B5B – Gastrointestinal stromal tumour, primary site
  • 2B5C – Endometrial stromal sarcoma, primary site
  • 2B5D – Malignant mixed epithelial mesenchymal tumour, primary site
  • 2B5E – Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site
  • 2B5F – Sarcoma, not elsewhere classified, primary site
  • 2B5G – Myosarcoma of uterus, part not specified
  • 2B5H – Well differentiated lipomatous tumour, primary site
  • 2B5J – Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites
  • 2B5K – Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites
  • 2B5Y – Other specified malignant mesenchymal neoplasms
  • 2B5Z – Malignant mesenchymal neoplasm of unspecified type

Foundation entity

Rhabdomyosarcoma, primary site – http://id.who.int/icd/entity/800945476

Allowed postcoordination axes

Part of: 02: Neoplasms